Health System

2020 is the 25th anniversary of The American Journal of Managed Care® and the October’s issue of the journal features an interview with Dr Kavita Patel, a nonresident fellow at the Brookings Institution and a primary care physician.

Pharmacists have an important role to play in the success of value-based payment models, according to panelists who discussed their health plan’s value initiatives at the Academy of Managed Care Pharmacy Nexus 2020 meeting.

Abstracts presented at CHEST 2020 looked at improving diagnosis of acute respiratory distress syndrome (ARDS) with machine learning and the development of intensive care unit delirium in hospitalized patients with ARDS.

Marty Makary, MD, MPH, kicked off the Academy of Managed Care Pharmacy Nexus 2020 meeting with a call to action around reducing overprescribing, increasing price transparency, and recapturing the public’s trust in the health care system.

Attendees at the Academy of Managed Care Pharmacy (AMCP) Nexus 2020 meeting will hear a keynote from a surgeon who has become more visible over the past year and a half discussing what he says are “structural problems” behind the cost of US health care.

Health care organizations can help spur growth among physicians through incorporating key experiences, such as out-of-expertise skill building and cross-functional projects, in their physician leadership development programs.

Using a seamlessly shared inpatient-outpatient electronic health record was associated with greater rates of postdischarge follow-up delivered through telemedicine or laboratory monitoring and without an in-person office visit.

To address rising prices of private health insurance, employers are considering several strategies, including narrow networks and decreased reliance on intermediaries.

Addressing coronavirus disease 2019 (COVID-19) means addressing racism, according to 2 experts in the latest episode of Managed Care Cast.

As the pandemic contributed to a significant decrease in the use of health care services in 2020, an analysis finds that employer health care benefit costs will likely increase in 2021 to address this deferral in care.

At the 1-year mark, following their first myocardial infarction (MI, or heart attack), heart failure hospitalizations and all-cause mortality were higher among patients who also had cardiogenic shock vs those who did not.

Family premiums for employer-sponsored health insurance rose 4% over the past year, averaging $21,342, according to Kaiser Family Foundation (KFF) study findings, with workers contributing $5588 in out-of-pocket costs.

Patient-provider communication quality metrics at safety net hospitals are indirectly affected by changes in regional market factors that influence patients’ demand for care.

As employers seek to gain a pulse of what the health care benefit cost trend will be for the coming year, the Business Group on Health will be monitoring several factors, including the impact of the pandemic, efficacy of virtual care, and deferral in care delivery.

Blythe Adamson, PhD, MPH, of Flatiron Health, discusses study results she presented at the annual American Society of Clinical Oncology meeting on the use of immune checkpoint inhibitors in end-of-life care

Results showed variation by age, gender, and partisan affiliation. But there's agreement on the need to lower the cost of prescription drugs.

Patients hospitalized for acute heart failure during the coronavirus disease 2019 (COVID-19) pandemic had more advanced disease and were more symptomatic, according to study results out of Australia.

Treatment guidelines for comorbid depression and migraine are warranted to ensure optimal efficacy and avoid possible pitfalls in psychopharmacotherapy, according to study results.

Research from the American Cancer Society suggests that more young people are being introduced to nicotine via e-cigarettes.

Efficacy and safety of atezolizumab as first-line therapy for metastatic non–small cell lung cancer (NSCLC) with high levels of PD-L1 expression is not known, the authors said.

In the real world, dupilumab has been as effective as the results in clinical trials, and patients are seeing low exacerbation rates, emergency department visits, and hospitalizations, explained Neal Jain, MD, FAAP, FAAAAI.

Researchers found that 12% of patients underwent testing even after care teams determined they were actively dying of chronic obstructive pulmonary disease (COPD) and the aim of care shifted to comfort.

Pediatric patients who had a referral from their pediatric rheumatologist and continued insurance coverage saw decreased delays when transitioning to an adult rheumatology clinic.

A FAIR Health review finds a dramatic drop in dental claims in March and April 2020 due to COVID-19.

We should look forward to a safe, effective vaccine for coronavirus disease 2019 (COVID-19) but not expect it to be the ultimate panacea.